解读MALT1-RC3H1轴在调节GPX4蛋白稳定性方面的作用
Jun Wang1, Long Liao1, Beiping Miao1,2
1State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200032, China.
概括
研究人员发现,MALT1通过控制GPX4蛋白水平来调节铁亡. 向MALT1诱导癌细胞死亡,并增强现有的癌症疗法,为癌症治疗提供了一种新的策略.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 细胞死亡机制 细胞死亡机制
背景情况:
- 铁,一种依赖于铁的细胞死亡形式,是一个有前途的癌症治疗标.
- GPX4是铁亡的关键调节者,但其蛋白质调节尚未完全理解.
研究的目的:
- 为了确定GPX4蛋白稳定性的新型调节者.
- 调查针对MALT1进行癌症治疗的潜力.
主要方法:
- 进行了基于FACS的全基因组CRISPR查,以确定GPX4调节器.
- 利用救援测定和功能遗传查来验证发现.
- 研究了MALT1-RC3H1轴在GPX4无化和降解中的作用.
主要成果:
- 确定了MALT1作为GPX4蛋白稳定性的新型调节剂.
- 证明MALT1抑制可上调RC3H1,促进GPX4降解并诱导肝癌细胞中的铁亡.
- 表明向MALT1与索拉费尼布或雷戈拉费尼布协同作用,以增强各种癌症类型中的铁亡.
结论:
- 马尔特1-RC3H1轴调节GPX4的稳定性,提供了诱导铁灭的分子机制.
- 对MALT1的药理定位代表了癌症治疗的潜在治疗策略,特别是在组合疗法中.
相关概念视频
Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K
Activation and Inactivation of G Proteins
6.7K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
6.7K
GTPases and their Regulation
8.3K
Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒ small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
Large G-proteins,...
8.3K
Export of Misfolded Proteins out of the ER
3.5K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.5K
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
Protein Folding Quality Check in the RER
3.7K
ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
3.7K


